Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Peperidine-flavan alkaloid compounds derived from African herb tea kinkeliba as anti-diabetic agents
Method for altering the lifespan of eukaryotic organisms
Femtocell network for determining location of a mobile device
Lighted footwear
Extension arm with light for a road construction machine
Device and partial mold for the production of rotor blades for wind power plants and methods for the production
  Randomly Featured Patents
Structures and structure forming methods
Process for microbial barrier vent to a foil package
Interactive video production system
Auxiliary lenses unit for glasses
Pea3 is a tumor suppressor
Stop means for use in a rod guiding apparatus
Control of parasitic nematode ova with Bacillus sphaericus
Ceramic optical parts and production methods thereof
Clip-on computer disc holder
Power transmission